Skip to content
Hugin
A long grey warehouse and closed loading door stand beside an empty concrete apron in mist.

Hugin News

FTC sues to block Covetrus's $3.5 billion purchase of veterinary distributor MWI

2 min read

Original editorial artwork from the Hugin archive; a generated warehouse illustration, not a Covetrus or MWI facility.

The FTC and state attorneys general are challenging Covetrus's proposed acquisition of MWI Veterinary Supply, according to the agency's November 13 announcement. The FTC alleges the deal would combine the two largest suppliers in two veterinary distribution markets and raise costs. Those are the government's allegations, not a court's findings or proof that pet owners' prices have already changed.

competitionveterinary-caremergersconsumer-costsfederal-enforcement
source receipt
1
source host
1
read time
2min
primary source
Linked

The Federal Trade Commission says it has sued to block Covetrus and its owners from buying MWI Veterinary Supply for $3.5 billion. The agency alleges the proposed combination would raise costs for veterinary clinics, reduce service quality and increase prices for pet owners.

The FTC's November 13 announcement describes a lawsuit, not a ruling that the transaction is unlawful or a finding that those price effects have occurred.

What the companies supply

Covetrus and MWI distribute pharmaceuticals, vaccines, surgical supplies and other products used in veterinary clinics, along with associated services. Their customers range from independent practices with one veterinarian to corporate accounts with hundreds of clinic locations in the United States.

The FTC says its complaint identifies two markets: veterinary clinic distribution and distribution to large corporate accounts. It alleges the deal would combine the two largest suppliers in both.

According to the agency's description of the complaint, the companies' national distribution networks support quick deliveries and discounts or rebates that smaller rivals cannot match. That is part of the FTC's competition case, not an independently established description of every rival's capabilities.

The alleged loss of competition

The FTC alleges Covetrus and MWI compete on prices and service terms. Its announcement says the complaint describes Covetrus responding to MWI pricing with lower prices and rebates through its VetSuite program.

The agency also points to Vetcove, a platform through which veterinarians can compare prices and use one distributor's pricing in negotiations with another. It alleges that this intensified competition between the two suppliers.

The FTC further alleges that structural challenges make market entry difficult and that specialty distributors and other suppliers do not provide a meaningful competitive constraint on veterinary clinic distributors. These assertions remain allegations to be tested in the case.

What happens next

The commission voted 2–0 to authorize seeking a permanent injunction. It says the complaint was filed in the U.S. District Court for the Southern District of New York and joined by state attorneys general, including Arizona's.

The announcement identifies MWI's seller as parent company Cencora and Covetrus's owners as Clayton, Dubilier & Rice and TPG. It does not report a court decision blocking the acquisition. A later court order or company response would add information beyond this announcement.

Source links